JRCT ID: jRCT2080224828
Registered date:09/08/2019
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 19/08/2019 |
Target sample size | 300 |
Countries of recruitment | Japan,North America,null |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : Selonsertib Therapeutic category code : 219 Other cardiovascular agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | efficacy exploratory |
---|---|
Secondary Outcome | efficacy exploratory |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | <= 80age old |
Gender | Both |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT04026165,JapicCTI-194911 |
Contact
Public contact | |
Name | |
Address | |
Telephone | |
JPClinicalOperations@gilead.com | |
Affiliation | |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |